On the recordFebruary 7, 2024
Now, we have been discussing the promise of biosimilars to lower the cost in a market oriented, competitive way.
Source
congress.govNow, we have been discussing the promise of biosimilars to lower the cost in a market oriented, competitive way.
Cassidy emphasizes the potential of biosimilars to reduce drug costs without government regulation.
Share
More from Bill Cassidy
If I were president, I'd be focused on what that family around the kitchen table is looking at as they go through their bills.